Austria Strips Pfizer Of Lipitor Patent

Law360, New York (March 29, 2005, 12:00 AM EST) -- In a victory for Ranbaxy Pharmaceuticals, Austria’s patent office has stripped Pfizer Inc. of its patent for the blockbuster cholesterol-lowering drug Lipitor.

The U.S. drug maker’s patent was successfully challenged by India’s largest pharmaceutical company, which is also challenging the Lipitor patent in other countries, including the U.S.

Pfizer said Tuesday it would appeal the decision, which only applies to the Austrian market.

Pfizer said it was confident it would, on appeal, be able to make a compelling argument in support of its patent.

Pfizer holds...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.